Join
Live feed
·
SECFilingvia Quantisnow
Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SIOX· Sio Gene Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SIOX (Sio Gene Therapies Inc.) and more on Quantisnow.

Sio Gene Therapies Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits | Quantisnow